Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
Revenue
441
115
113
112
98
97
Revenue Growth (YoY)
14%
19%
19%
14%
1%
4%
Cost of Revenue
157
42
38
39
35
35
Gross Profit
284
73
74
73
63
61
Selling, General & Admin
212
55
51
51
54
47
Research & Development
30
9
8
7
6
7
Operating Expenses
257
65
65
64
61
58
Other Non Operating Income (Expenses)
2
1
0
0
0
-15
Pretax Income
14
6
7
3
-2
-16
Income Tax Expense
5
4
0
2
-1
0
Net Income
9
2
6
1
0
-16
Net Income Growth
-169%
-112.99%
-400%
-150%
-100%
433%
Shares Outstanding (Diluted)
50.66
50.66
48.77
45.37
42.23
41.88
Shares Change (YoY)
21%
21%
17%
9%
0%
2%
EPS (Diluted)
0.19
0.04
0.13
0.02
-0.01
-0.39
EPS Growth
-162%
-112%
-344%
-158%
-107%
306%
Free Cash Flow
0
-7
17
11
-20
8
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
64.39%
63.47%
65.48%
65.17%
64.28%
62.88%
Operating Margin
5.89%
6.08%
7.96%
7.14%
2.04%
2.06%
Profit Margin
2.04%
1.73%
5.3%
0.89%
0%
-16.49%
Free Cash Flow Margin
0%
-6.08%
15.04%
9.82%
-20.4%
8.24%
EBITDA
39
10
12
11
5
6
EBITDA Margin
8.84%
8.69%
10.61%
9.82%
5.1%
6.18%
D&A For EBITDA
13
3
3
3
3
4
EBIT
26
7
9
8
2
2
EBIT Margin
5.89%
6.08%
7.96%
7.14%
2.04%
2.06%
Effective Tax Rate
35.71%
66.66%
0%
66.66%
50%
0%
Follow-Up Questions
What are Artivion Inc's key financial statements?
According to the latest financial statement (Form-10K), Artivion Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for AORT?
Artivion Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Artivion Inc's revenue broken down by segment or geography?
Artivion Inc largest revenue segment is Medical Devices, at a revenue of 345,825,000 in the most earnings release.For geography, United States is the primary market for Artivion Inc, at a revenue of 214,075,000.
Is Artivion Inc profitable?
no, according to the latest financial statements, Artivion Inc has a net loss of $0